About Index Trending news
Analyze
Pricing
ImaginAb

ImaginAb

ImaginAb

ImaginAb clinically manages cancer and autoimmune diseases via molecular imagingby re-engineering antibodies into small proteins.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Angel
$8,000,000
Venture capital
$5,340,000
Employees

Unknown size

Locations
$8,000,000 Angel
PE Hub

ImaginAb grabs $8 mln